Ruben Krupik
Chairman at BANK HAPOALIM B.M.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Yaron Meyer | M | 45 | 16 years | |
| Ofer Gonen | M | 49 |
Andromeda Biotech Ltd.
 Andromeda Biotech Ltd. Pharmaceuticals: MajorHealth Technology Andromeda Biotech Ltd. develops treatment for autoimmune diabetes. The company was founded in 2007 and is headquartered in Rehovot, Israel. | 21 years |
| Aharon Schwartz | M | 80 |
BioCancell Therapeutics, Inc.
 BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | 18 years |
| Amir Bachar | M | 52 | 14 years | |
| Jonathan Burgin | M | 63 |
BioCancell Therapeutics, Inc.
BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | 13 years |
| Eti Ben-Zeev | F | 56 | 14 years | |
| Gilad Bloch | M | 53 | 11 years | |
| Yadin Antebi | M | 53 | 11 years | |
| David Avner | M | 72 | 5 years | |
| Assaf Segal | M | 51 | 9 years | |
| Ronit Abramson Rokach | M | 66 | 6 years | |
| Dalia Lev | F | 76 | 6 years | |
| Ofer Goldberg | M | 52 |
BioCancell Therapeutics, Inc.
BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | 21 years |
| Smadar Nestor | F | - | 16 years | |
| Anthony Arteaga | M | - |
Arteaga Construction, Inc.
 Arteaga Construction, Inc. Engineering & ConstructionIndustrial Services Arteaga Construction, Inc. is a minority-owned business that provides construction services including highway, bridge and street. The company was founded by Anthony Arteaga in 1986 and is headquartered in Milwaukee, WI. | 38 years |
| Noam Hanegbi | M | 65 | 5 years | |
| Clara Zwergel | F | - | - | |
| Amit Oberkovich | M | 59 | 5 years | |
| David Zvilichovsky | M | 62 | 5 years | |
| Yigal Barkat | M | - | 2 years | |
| Yael Almog | F | 56 | 7 years | |
| Ram Gev | M | 49 | 4 years | |
| Roni Solomon | F | - | 18 years | |
| Guy Kalif | M | 52 | 17 years | |
| Keren David-Zarbiv | F | - | 11 years | |
| Tamar Koblenz | F | - | 3 years | |
| Dov Kotler | M | 67 | 5 years | |
| Ety Klinger | M | 62 | 10 years | |
| Israel Trau | M | 68 | 4 years | |
| Odelia Levanon | M | 60 | 2 years | |
| Yoel Mintz | M | 70 | 3 years | |
| Joshua Hazenfratz | M | 70 | 17 years | |
| Ronit Schwartz | F | 58 | 3 years | |
| Iris Sadeh | F | - | 12 years | |
| Eilon Asculai | M | - | 17 years | |
| Merav Ben Shushan Cohen | M | - | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Ari Pinto | M | 62 | 39 years | |
| Sharon Malka | F | 51 | - | |
| Aharon Yaari | M | 72 | 2 years | |
| Avri Havron | M | 76 | 3 years | |
| Jonathan Kaplan | M | 66 | 8 years | |
| Samuel Rubinstein | M | 59 | 9 years | |
| Jacob Orbach | M | 68 | 38 years | |
| Zion Kenan | M | 68 | 37 years | |
| Efrat Yavetz | F | 60 | 30 years | |
| Avi Zigelman | M | 67 | - | |
| Gil Milner | M | 57 | - | |
| Meron Mann | M | 72 | 10 years | |
| Joshua Levine | M | 59 | 5 years | |
| Gal Cohen | M | 51 | 13 years | |
| Shlomo Dagan | M | - |
Andromeda Biotech Ltd.
Andromeda Biotech Ltd. Pharmaceuticals: MajorHealth Technology Andromeda Biotech Ltd. develops treatment for autoimmune diabetes. The company was founded in 2007 and is headquartered in Rehovot, Israel. | - |
| Oded Eran | M | 69 | 4 years | |
| Nirit Freikorn | F | 50 | - | |
| Hagit Hamdani Meiroviz | F | 53 | 5 years | |
| Sigal Aviel | M | 60 | 1 years | |
| Adi Kaplan | M | 51 | 2 years | |
| Ofer Koren | M | 53 | - | |
| Yael Dromi | F | 51 | 2 years | |
| Golan Scherman | M | 55 | 8 years | |
| Yaron Shoham | M | - | 7 years | |
| Shahar Markovitch | M | 46 | 1 years | |
| Sigalia Heifetz | F | 62 | 11 years | |
| Avraham Kochva | M | 62 | - | |
| Erez Yosef | M | 56 | 3 years | |
| Asaf Azulay | M | 40 | 5 years | |
| Roland Frösing | M | 64 | 7 years | |
| Gil Barzilay | M | - | - | |
| Carsten Henke | M | 58 | 6 years | |
| Richard Kaplan | M | 68 | 3 years | |
| Merana Tamir | M | - |
Andromeda Biotech Ltd.
Andromeda Biotech Ltd. Pharmaceuticals: MajorHealth Technology Andromeda Biotech Ltd. develops treatment for autoimmune diabetes. The company was founded in 2007 and is headquartered in Rehovot, Israel. | - |
| Daniel Shinar | M | 42 | 1 years | |
| Amir Aviv | M | 52 | 3 years | |
| Yair Seroussi | M | 68 | 7 years | |
| Ilan Mazur | M | 77 | 37 years | |
| Sarit Firon | F | 58 | 3 years | |
| Ronen Stein | M | 57 | 3 years | |
| Rachel Eren | M | - |
Andromeda Biotech Ltd.
Andromeda Biotech Ltd. Pharmaceuticals: MajorHealth Technology Andromeda Biotech Ltd. develops treatment for autoimmune diabetes. The company was founded in 2007 and is headquartered in Rehovot, Israel. | - |
| Aviv Boim | M | 56 |
BioCancell Therapeutics, Inc.
BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | 4 years |
| Gil Bianco | M | 72 | 3 years | |
| Dana Elias | M | - |
Andromeda Biotech Ltd.
Andromeda Biotech Ltd. Pharmaceuticals: MajorHealth Technology Andromeda Biotech Ltd. develops treatment for autoimmune diabetes. The company was founded in 2007 and is headquartered in Rehovot, Israel. | - |
| Orit Lidor | F | 45 | - | |
| Amos Bankirer | M | 72 | - | |
| Isaac Kohlberg | M | 71 | 5 years | |
| Moshe Koren | M | 85 | 28 years | |
| Ofer Levy | M | 70 | 14 years | |
| Dan Alexander Koller | M | 53 | 10 years | |
| Monique Ben-Am | F | - |
BioCancell Therapeutics, Inc.
BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | 4 years |
| Israel Tapouchi | M | 78 | - | |
| Anat Benish | F | 60 | - | |
| Amir Weitmann | M | - | 7 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Israel | 86 | 95.56% |
| United States | 6 | 6.67% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Ruben Krupik
- Personal Network
